Corvus Pharmaceuticals, Inc. $69 Million Common Stock Offering

Ambrogio Visconti

Davis Polk advised the joint book-running managers in connection with a $69 million SEC-registered common stock offering by Corvus Pharmaceuticals, Inc. Credit Suisse, Jefferies, Guggenheim Securities…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now